【24h】

In reply to Dr. Saini et al.

机译:在回复Saini博士等。

获取原文
获取原文并翻译 | 示例
           

摘要

We thank Saini et al. for their interest in our article (1). The letter emphasizes the importance of lung V_5 by citing several references (2-4), which indicate that lung V_5 is a good predictor of pneumonitis. However, Wang et al. (2, 3) concluded that V_5 alone does not determine the onset of lung complications. Furthermore, lung data from these studies are from esophagus cancer patients undergoing a postsurgical procedure, which is believed to trigger postoperative complications in lung (4) and from non-small-cell lung cancer patients (3), who would have very different lung functions from the patients in our study.The following statement, "the errors in the dose-volume histogram of the normal lung can be up to 25% at dose levels of < 10 Gy" is misleading. Jang et al. (4) do show that a maximum of 25% difference in lung V_5 is observed between Monte Carlo simulations and treatment planning system calculations but only in mesothelioma patients. In those unusual plans, large fields delivering >1200 MU are used for a target dose of 180 cGy. In other plans, differences in lung V_5between Monte Carlo simulations and treatment planning system calculations are 1.0% to 7.2%.
机译:我们感谢Saini等。因为他们对我们的文章(1)感兴趣。该信通过引用多个参考文献(2-4)强调了肺V_5的重要性,表明肺V_5是肺炎的良好预测指标。然而,王等。 (2,3)得出结论,仅V_5并不能决定肺部并发症的发作。此外,这些研究的肺部数据来自接受术后手术的食道癌患者,据信这会触发肺部术后并发症(4),以及非小细胞肺癌患者(3),他们的肺功能有很大不同以下陈述“在<10 Gy的剂量水平下,正常肺的剂量-体积直方图误差可能高达25%”是令人误解的。 Jang等。 (4)确实显示,在Monte Carlo模拟和治疗计划系统计算之间,肺V_5的最大差异为25%,但仅在间皮瘤患者中观察到。在那些不寻常的计划中,将提供> 1200 MU的大场用于180 cGy的目标剂量。在其他计划中,蒙特卡罗模拟和治疗计划系统计算之间的肺V_5差异为1.0%至7.2%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号